NVIDIA CorporationNVIDIA makes a new investment in Verily, extending its healthcare AI bet.

Verily Health Inc. has received new investment support from NVIDIA, as the company extends its March fundraising, with existing investor CU Healthcare Innovation Fund II, LP also making an additional investment. The funding will support Verily's precision health AI strategy, including scaling adoption of its Verily Pre Platform and growing its patient engagement offering, Verily Me. Verily and NVIDIA previously announced a collaboration in October 2025, and researchers using the Verily Pre Platform will be able to leverage NVIDIA AI libraries and frameworks, including NeMo, Parabricks, RAPIDS, and NVIDIA B200 GPUs. Verily developed Forecast 1.0™, a foundation model integrating genomics and EHR data, in collaboration with NVIDIA, achieving improved predictive performance and computational efficiency. Stephen Gillett, Chairman and CEO of Verily, welcomed NVIDIA as a new investor, noting the investments strengthen the company's ability to build a trusted foundation for healthcare.
NVIDIA CorporationNVIDIA makes a new investment in Verily, extending its healthcare AI bet.
Alphabet Inc Class CVerily secures new investment from NVIDIA and CU Healthcare Innovation Fund to scale its precision health AI platform.